SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-009980
Filing Date
2024-03-14
Accepted
2024-03-14 17:02:39
Documents
1
Period of Report
2022-12-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3972
  Complete submission text file 0001493152-24-009980.txt   5469
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SHUTTLE PHARMACEUTICALS HOLDINGS, INC. ONE RESEARCH COURT, SUITE 450 ROCKVILLE MD 20850
Business Address
Senanayake Chris (Reporting) CIK: 0001945766 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41488 | Film No.: 24751160